Showing 51-60 of 648 results for "".
Adult Moyamoya Syndromes: Update on Diagnosis and Treatment
https://practicalneurology.com/columns/practice-management/PN0909_05-php/30891/Aggressive interventions are indicated for this condition, which is associated with significant morbidity.Hirayama Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/video-case-solution-hirayama-disease/30535/PD GENEration and Barriers to Parkinson Diagnosis - Part 2
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pd-generation-and-barriers-to-parkinson-diagnosis-part-2/30096/Richard Huckabee is a patient living with Parkinson disease and a Parkinson’s Foundation "Aware in Care" ambassador and research advocate. Mr. Huckabee is enrolled in the PD GENEration study, a national initiative offering no-cost genetic testing and counseling for people with Parkinson disease, andRelapsing and Progressive Multiple Sclerosis: Understanding the Differences
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapsing-and-progressive-multiple-sclerosis-understanding-the-differences/30761/Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.On the Role of Caregivers in Epilepsy Treatment
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/on-the-role-of-caregivers-in-epilepsy-treatment/32065/A Discussion with Greg Grunberg, Host of the “The Care Giver” SeriesImaging Biomarkers: Challenges, Opportunities, and the Road Ahead
https://practicalneurology.com/diseases-diagnoses/imaging-testing/imaging-biomarkers-challenges-opportunities-and-the-road-ahead/30441/Raising Urate With Inosine to Potentially Slow Progression of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-focus/30688/Results of the Phase II SURE-PD study show inosine is safe and tolerable and raises urate levels, which have been inversely related to Parkinson's progression. Still, patients are cautioned against self-medicating before the next phase of this research effort is completed.Anti-Leucine–Rich Glioma-Inactivated 1 Antibody Encephalitis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/anti-leucinerich-glioma-inactivated-1-antibody-encephalitis/30288/Dementia Insights: Toward New Clinical Criteria for Alzheimers Disease and Mild Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-toward-new-clinical-criteria-for-alzheimers-disease-and-mild-cognitive-impairment/30840/One development from this summer's International Conference on Alzheimers Disease is progress toward new criteria for Alzheimers and MCI.Moyamoya Disease
https://practicalneurology.com/diseases-diagnoses/stroke/moyamoya-disease/31617/MRI and catheter angiogram diagnosis, followed by surgical revascularization performed at high-volume centers by experienced teams, substantially and durably reduces stroke risk from Moyamoya.